Management of Resistant Hypertension
The best approach to managing resistant hypertension is to first exclude pseudoresistance, then optimize lifestyle modifications, ensure appropriate diuretic-based therapy, and add spironolactone as a fourth-line agent in suitable patients. 1, 2
Confirming True Resistant Hypertension
- Resistant hypertension is defined as seated office BP >140/90 mm Hg in a patient treated with three or more antihypertensive medications at optimal doses including a diuretic 1
- Exclude pseudoresistance causes before proceeding with further management:
- Approximately 50% of patients diagnosed with resistant hypertension have pseudoresistance rather than true resistant hypertension 1
- Review all medications and substances that may interfere with BP control (NSAIDs, oral contraceptives, decongestants, stimulants) 2
Screening for Secondary Causes
- Consider screening for secondary hypertension in patients with:
- Early onset hypertension (<30 years of age)
- Resistant hypertension
- Sudden deterioration in BP control
- Hypertensive urgency/emergency 1
- Common secondary causes include:
- Basic screening should include thorough history, physical examination, basic blood biochemistry (sodium, potassium, eGFR, TSH), and urinalysis 1
- Further investigations should be carefully chosen based on clinical suspicion 1
Optimizing Lifestyle Modifications
- Dietary salt restriction to less than 1500 mg/day can reduce systolic and diastolic BP by 5-10 and 2-6 mm Hg, respectively 1, 2
- Weight loss of 10 kg is associated with an average 6.0 mm Hg reduction in systolic and 4.6 mm Hg reduction in diastolic BP 1
- Regular aerobic exercise for at least 30 minutes on most days of the week can produce average reductions of 4 mm Hg in systolic and 3 mm Hg in diastolic BP 1
- Limit alcohol intake to no more than 2 drinks per day for men and 1 drink per day for women 1
- Adopt a DASH diet (high in fruits, vegetables, low-fat dairy products, potassium, magnesium, and calcium; low in saturated fats) 1, 2
Pharmacological Management Algorithm
Optimize current regimen:
Add fourth-line agent:
- Spironolactone is the preferred fourth-line agent for patients with serum potassium <4.5 mmol/L and eGFR >45 ml/min/1.73m² 1, 2, 3
- Spironolactone is indicated for add-on therapy for hypertension not adequately controlled on other agents 4
- Monitor serum potassium and renal function when using spironolactone, especially with reduced renal function 2
Alternative fourth-line agents if spironolactone is contraindicated or not tolerated:
Consider combination therapy including:
Special Considerations
- Patients with CKD have a higher prevalence of resistant hypertension (40% in the CRIC Study) 1
- For patients with CKD, consider using modalities that do not involve iodinated contrast when imaging for renal artery stenosis 1
- Treatment of obstructive sleep apnea with CPAP may improve BP control, though benefits in intervention trials have been variable 1
- Simplify medication regimens when possible to improve adherence, including use of long-acting combination products to reduce pill burden 1, 2
- Involve patients in their care through home BP monitoring and maintenance of BP diaries 1
Referral Recommendations
- Resistant hypertension should be managed in specialist centers with sufficient expertise and resources 1
- Consider referral to a specialist (nephrologist, cardiologist, endocrinologist) if BP remains uncontrolled despite optimal therapy with 4+ medications 1, 2
- Refer for further investigation and management of suspected secondary hypertension to a specialist center 1
Common Pitfalls to Avoid
- Failing to confirm true resistant hypertension before escalating therapy 1, 2
- Not screening for secondary causes, especially in younger patients or those with sudden BP deterioration 1
- Inadequate dosing, lack of using long-acting diuretics, and suboptimal combinations (observed in nearly half of patients with resistant hypertension) 7
- Overlooking medication nonadherence, which accounts for approximately 50% of apparent treatment-resistant hypertension 1
- Neglecting the importance of sodium restriction in the management plan 1